October 18, 2022 12:55 PM EDT
Pharma
Marketing

Mar­ket­ingRx roundup: No­var­tis spot­lights breast can­cer pa­tient sto­ries; Cal­i­for­nia al­lots $40M for opi­oid ad cam­paign

Beth Snyder Bulik

Senior Editor

No­var­tis’ spring TV cam­paign for breast can­cer drug Kisqali fea­tured a first-ever re­al pa­tient spokesper­son, and now the phar­ma is shar­ing even more sto­ries this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times